The Bristol-Myers Squibb Company (BMY) ROIC is 13.6%, compared to the industry median of (14.6%) and the 5-year historical average of 10.2%.
The Bristol-Myers Squibb Company (BMY) ROIC minus WACC is 8.7%, compared to the industry median of (9.1%) and the 5-year historical average of 5.6%.
The Bristol-Myers Squibb Company (BMY) ROE is (42.3%), compared to the industry median of (18.5%) and the 5-year historical average of 2.0%.
The Bristol-Myers Squibb Company (BMY) ROCE is 14.0%, compared to the industry median of (12.3%) and the 5-year historical average of 10.1%.